Latest News
Novo buying up ‘more of its supply chain’ in Single Use Systems deal
Novo buying up ‘more of its supply chain’ in Single Use Systems deal
Novo Holdings, the investment company behind pharma giant Novo Nordisk, will acquire a controlling stake in bioprocess fluid management firm Single Use Support.
Deal-Making
Novo Holdings, the investment company behind pharma giant Novo Nordisk, will acquire a controlling stake in bioprocess fluid management firm Single Use Support.
Sartorius has partnered with Sanofi to co-develop and market an integrated and continuous biomanufacturing (ICB) platform to increase downstream efficiency.
Facilities & Capacity
Sanofi will double production capacity at a monoclonal antibody (mAb) facility near Paris as part of a major investment in its home country France.
Solvias will open a biotech site in Research Triangle Park, North Carolina to enhance its analytical testing services for the cell and gene therapy (CGT) and biologics space.
Global Markets
.jpg?width=700&auto=webp&quality=80&disable=upscale)
Experts at Abu Dhabi Global Healthcare Week (ADGHW), United Arab Emirates (UAE) discussed the importance of having multiple stakeholder conversations to facilitate the transition from healthcare to health globally.
A revised version of the US BIOSECURE Act will give US biopharma firms until 2032 to sever ties with Chinese suppliers. For WuXi Biologics, this could lead to share buybacks, privatization, or an all-out sale says one analyst.
Regulations
A revised version of the US BIOSECURE Act will give US biopharma firms until 2032 to sever ties with Chinese suppliers. For WuXi Biologics, this could lead to share buybacks, privatization, or an all-out sale says one analyst.
The US FDA has approved Beqvez (fidanacogene elaparvovec), Pfizer’s adeno-associated virus (AAV) based gene therapy for the treatment of hemophilia B.
Therapeutic Class
Sanofi has signed a licensing deal worth up to $1.2 billion with Novavax to commercialize the latter’s adjuvanted COVID-19 vaccine and use the technology to create its own flu shot.
Singapore’s SCG Cell Therapy and A*STAR, an official Singapore investor, will team up to build new joint laboratory research labs for cellular immunotherapies.
Upstream & Downstream Processing
Novo Holdings, the investment company behind pharma giant Novo Nordisk, will acquire a controlling stake in bioprocess fluid management firm Single Use Support.
Repligen says it is looking at new modalities and its filtration franchise to drive momentum following a mixed first quarter 2024.